文献速递神经肿瘤

长链非编码RNA MEG3调控胶质瘤增殖、凋亡与自噬并与预后相关

Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
PubMed 文献 · J Neurooncol · 2018-10-03

研究检测79例胶质瘤组织及癌旁正常脑组织、胶质瘤细胞与正常人星形胶质细胞中MEG3表达,用Kaplan-Meier和Cox回归分析生存,MTT、流式细胞术和免疫荧光检测细胞增殖、凋亡与自噬。结果显示MEG3在胶质瘤组织和细胞中显著下调,低表达与高级别WHO分级、低KPS、IDH野生型和肿瘤复发相关,且低表达患者总生存差;MEG3过表达可抑制胶质瘤细胞增殖并促进凋亡和自噬。

要点

  • MEG3在胶质瘤组织与细胞中显著下调,且与WHO分级负相关。
  • 低MEG3表达与高级别WHO分级、低KPS、IDH野生型和肿瘤复发相关,患者总生存差。
  • MEG3过表达可抑制胶质瘤细胞增殖并促进凋亡和自噬。

核心结论

  • MEG3在胶质瘤细胞增殖、凋亡和自噬中起重要作用,并与胶质瘤患者预后显著相关,可能为预测预后和治疗干预提供新靶点。

研究设计与样本

  • 检测79例胶质瘤组织及癌旁正常脑组织、胶质瘤细胞与正常人星形胶质细胞中MEG3表达水平,采用qRT-PCR。
  • 采用Kaplan-Meier和Cox回归方法进行生存分析。
  • 采用MTT法、流式细胞术和免疫荧光法检测MEG3对胶质瘤细胞增殖、凋亡和自噬的影响。

主要发现

  • MEG3在胶质瘤组织和细胞系中表达显著下调,并与胶质瘤患者WHO分级负相关。
  • 低MEG3表达与高级别WHO分级、低Karnofsky功能评分(KPS)、IDH野生型和肿瘤复发显著相关。
  • MEG3低表达患者总生存差。
  • MEG3下调、高级别WHO分级、低KPS、IDH野生型和肿瘤复发是胶质瘤患者的独立不良预后指标。
  • 体外实验显示MEG3过表达显著抑制胶质瘤细胞增殖,同时促进凋亡和自噬。

临床怎么用

  • 作者认为MEG3可能为胶质瘤预后预测和治疗干预提供新靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Accumulating evidence indicates that dysregulated long noncoding RNAs (lncRNAs) play critical roles in tumorigenesis and cancer progression. LncRNA-maternally expressed gene 3 (MEG3) has been shown to be involved in the initiation and development of several cancers, including glioma. However, the clinical prognostic value of MEG3 in glioma has not yet been fully elucidated. METHODS: The expression levels of MEG3 were detected in 79 glioma tissues and adjacent normal brain tissues, as well as, glioma cells and normal human astrocytes by qRT-PCR. Kaplan-Meier and Cox regression methods were utilized for the survival analysis. MTT assay, flow cytometry, and immunofluorescence assay were carried out to detect the impact of MEG3 on glioma cell proliferation, apoptosis, and autophagy. RESULT: The current results showed that MEG3 expression was significantly downregulated in glioma tissues and cell line and negatively correlated with WHO grade in glioma patients. Low MEG3 expression was significantly associated with the advanced WHO grade, low Karnofsky performance score (KPS), IDH wild-type, and tumor recurrence. Patients displaying a low expression of MEG3 contributed to poor overall survival. The downregulated level of MEG3, advanced WHO grade, low KPS, IDH wild-type, and tumor recurrence were independent poor prognostic indicators in glioma patients. The in vitro experiments demonstrated that the MEG3 overexpression remarkably suppressed the proliferation while facilitating apoptosis and autophagy in glioma cells. CONCLUSIONS: These findings indicated a critical role of MEG3 in glioma cell proliferation, apoptosis, and autophagy. Also, the gene was found to be significantly associated with the prognosis in glioma patients. Thus, it might provide a new target for predicting prognosis and therapeutic intervention in glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Zhao H, Wang X, Feng X, et al. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma. J Neurooncol. 2018. PMID: 30284203. doi:10.1007/s11060-018-2874-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。